These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2414753)

  • 1. Transvenous cardioversion and defibrillation of ventricular tachyarrhythmias: current status and future directions.
    Saksena S; Calvo R
    Pacing Clin Electrophysiol; 1985 Sep; 8(5):715-31. PubMed ID: 2414753
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of electrical pacing and automatic cardioversion defibrillation for normal cardiac function recovery.
    Pekarsky V; Astrakhantsev Y; Belenkov Y; Gimrikh E; Oferkin A; Maslov M; Popov S; Pekarskaya M; Markov V; Vasiltsev Y
    Pacing Clin Electrophysiol; 1986 Nov; 9(6 Pt 2):1349-55. PubMed ID: 2432561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchronous intracardiac cardioversion.
    Zipes DP; Heger JJ; Miles WM; Prystowsky EN
    Pacing Clin Electrophysiol; 1984 May; 7(3 Pt 2):522-33. PubMed ID: 6204310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical transvenous cardioversion of recurrent life-threatening ventricular tachyarrhythmias: low energy synchronized cardioversion of ventricular tachycardia and termination of ventricular fibrillation in patients using a catheter electrode.
    Zipes DP; Jackman WM; Heger JJ; Chilson DA; Browne KF; Naccarelli GV; Rahilly GT; Prystowsky EN
    Am Heart J; 1982 May; 103(5):789-94. PubMed ID: 7072583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transvenous cardioversion for the management of recurrent ventricular arrhythmias.
    Bucknall CA; Lewis S; Vincent R; Jackson G; Jewitt DE; Chamberlain DA
    Br Heart J; 1987 Sep; 58(3):245-50. PubMed ID: 3663424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness of the methods of electric cardiac stimulation and low-energy cardioversion-defibrillation in the prevention and treatment of ventricular tachycardia and ventricular fibrillation].
    Pekarskiĭ VV; Gimrikh EO; Oferkin AI; Maslov MG; Vecherskiĭ IuIu; Popov SV; Pekarskaia MV; Porotov AV
    Kardiologiia; 1990 Nov; 30(11):86-90. PubMed ID: 2087041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular tachycardia rate and morphology determine energy and current requirements for transthoracic cardioversion.
    Kerber RE; Kienzle MG; Olshansky B; Waldo AL; Wilber D; Carlson MD; Aschoff AM; Birger S; Fugatt L; Walsh S
    Circulation; 1992 Jan; 85(1):158-63. PubMed ID: 1728445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporary transvenous cardioversion and defibrillation: a new method for practical tachyarrhythmia management.
    Luceri RM; Accorti PR
    Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 2):168-72. PubMed ID: 9121983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accepted, controversial, and speculative aspects of ventricular defibrillation.
    Crampton R
    Prog Cardiovasc Dis; 1980; 23(3):167-86. PubMed ID: 7001540
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of electrical pacemakers in the treatment of ventricular tachycardia and ventricular fibrillation.
    Kerr CR; Klein GJ; Cooper JA; Sharma AD
    Cardiovasc Clin; 1985; 16(1):215-37. PubMed ID: 3915712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of direct current countershock on ventricular late potentials.
    Volosin KJ; Greenspon AJ
    Pacing Clin Electrophysiol; 1987 Mar; 10(2):305-9. PubMed ID: 2437535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective randomized study of the clinical efficacy and safety of transvenous cardioversion for termination of ventricular tachycardia.
    Ciccone JM; Saksena S; Shah Y; Pantopoulos D
    Circulation; 1985 Mar; 71(3):571-8. PubMed ID: 3971528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of transvenous low energy cardioversion of atrial fibrillation in patients with a history of ventricular tachycardia: effects of rate and repolarization time on proarrhythmic risk.
    Simons GR; Newby KH; Kearney MM; Brandon MJ; Natale A
    Pacing Clin Electrophysiol; 1998 Feb; 21(2):430-7. PubMed ID: 9507545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transesophageal low-energy cardioversion in an animal model of life-threatening tachyarrhythmias.
    Cai YC; Fan SL; Feng DX; Gan SX; Feng JF; Kuang ZS; Li ZF
    Circulation; 1989 Nov; 80(5):1354-9. PubMed ID: 2805271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of shock timing on efficacy and safety of internal cardioversion for ventricular tachycardia.
    Li HG; Yee R; Mehra R; DeGroot P; Klein GJ; Zardini M; Thakur RK; Morillo CA
    J Am Coll Cardiol; 1994 Sep; 24(3):703-8. PubMed ID: 8077542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrical treatment of cardiac arrhythmias: defibrillation and cardioversion.
    Kerber RE
    Ann Emerg Med; 1993 Feb; 22(2 Pt 2):296-301. PubMed ID: 8434828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy of dual electrode systems for endocardial cardioversion of ventricular tachycardia: a prospective randomized crossover trial.
    Saksena S; An H
    Am Heart J; 1990 Jan; 119(1):15-22. PubMed ID: 2404386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical application of cardioversion.
    Zipes DP
    Cardiovasc Clin; 1970; 2(2):239-60. PubMed ID: 4950415
    [No Abstract]   [Full Text] [Related]  

  • 19. The implantable defibrillator in ventricular arrhythmias.
    Winkle RA
    Hosp Pract (Off Ed); 1983 Mar; 18(3):149-54, 156, 162 passim. PubMed ID: 6404753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventricular proarrhythmic effects of ventricular cycle length and shock strength in a sheep model of transvenous atrial defibrillation.
    Ayers GM; Alferness CA; Ilina M; Wagner DO; Sirokman WA; Adams JM; Griffin JC
    Circulation; 1994 Jan; 89(1):413-22. PubMed ID: 8281677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.